The first Cytosorbents trade was made in Q2 2015.
Since then Ken Griffin bought shares 35 more times and sold shares on 29 occasions. The investor sold all their shares in Q4 2024 and doesn't own any shares in Cytosorbents anymore.
Avg closing price
Price range
Sold -29.1 Thousand shares
Q4 2024
Avg closing price
$0.98
Price range
$0.74
-
$1.35
New holding (+29.1 Thousand shares)
Q3 2024
Avg closing price
$1.09
Price range
$0.70
-
$1.55
Sold -30.7 Thousand shares
Q4 2023
Avg closing price
$1.48
Price range
$1.08
-
$1.94
Sold 18.8% shares (-7.11 Thousand shares)
Q3 2023
Avg closing price
$2.87
Price range
$1.86
-
$4.03
Increased shares by 186.5% (+24.6 Thousand shares)
Q2 2023
Avg closing price
$3.16
Price range
$2.37
-
$3.65
New holding (+13.2 Thousand shares)
Q1 2023
Avg closing price
$3.00
Price range
$1.79
-
$4.17
Sold -127 Thousand shares
Q3 2022
Avg closing price
$1.95
Price range
$1.20
-
$2.46
Increased shares by 461.4% (+104 Thousand shares)
Q2 2022
Avg closing price
$2.30
Price range
$1.76
-
$3.22
Increased shares by 8.5% (+1.78 Thousand shares)
Q1 2022
Avg closing price
$3.58
Price range
$2.88
-
$4.23
Sold 66.2% shares (-40.7 Thousand shares)
Q4 2021
Avg closing price
$5.61
Price range
$4.05
-
$8.11
Increased shares by 95.9% (+30.1 Thousand shares)
Q3 2021
Avg closing price
$8.12
Price range
$7.00
-
$9.71
Increased shares by 32.9% (+7.78 Thousand shares)
Q2 2021
Avg closing price
$8.43
Price range
$7.55
-
$9.42
Sold 81.8% shares (-106 Thousand shares)
Q1 2021
Avg closing price
$9.53
Price range
$8.23
-
$11.48
Increased shares by 35.7% (+34.2 Thousand shares)
Q3 2020
Avg closing price
$9.02
Price range
$7.37
-
$11.54
Increased shares by 815.5% (+85.2 Thousand shares)
Q2 2020